Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis
2015
Purpose
Insomnia is an important adverse event of mechanical thromboprophylaxis. This sleep disorder has been reported as one of the commonest adverse events of the new oral anti-Xa anticoagulant darexaban, with similar rates to mechanical thromboprophylaxis in a randomized controlled trial (RCT). However, the perceived effect could have been biased because it was an open-label RCT. Therefore, we aimed to review the incidence of insomnia with non-vitamin K antagonist oral anticoagulants (NOACs).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
1
Citations
NaN
KQI